KRAS and lymphoma: Interestingly, chromosome 3 gain has not been observed in a BRCA1 driven murine breast cancer model [34], nor a KRAS driven model of non–small cell lung cancer [35] while frequent partial gain of this chromosome was described in a MYC driven murine model of lymphoma [36].